Strs Ohio trimmed its stake in shares of Cognex Corporation (NASDAQ:CGNX - Free Report) by 95.2% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 4,013 shares of the scientific and technical instruments company's stock after selling 80,106 shares during the period. Strs Ohio's holdings in Cognex were worth $197,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors also recently bought and sold shares of the stock. Geneos Wealth Management Inc. boosted its position in Cognex by 402.2% in the 1st quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company's stock worth $27,000 after purchasing an additional 736 shares in the last quarter. CIBC Private Wealth Group LLC lifted its stake in shares of Cognex by 74.8% in the 3rd quarter. CIBC Private Wealth Group LLC now owns 764 shares of the scientific and technical instruments company's stock valued at $35,000 after purchasing an additional 327 shares during the period. Miller Global Investments LLC acquired a new stake in Cognex during the fourth quarter valued at $39,000. Caitong International Asset Management Co. Ltd acquired a new stake in Cognex during the fourth quarter valued at $39,000. Finally, Larson Financial Group LLC increased its holdings in Cognex by 202.7% in the fourth quarter. Larson Financial Group LLC now owns 1,105 shares of the scientific and technical instruments company's stock valued at $40,000 after buying an additional 740 shares in the last quarter. 88.12% of the stock is currently owned by hedge funds and other institutional investors.
Cognex Price Performance
CGNX stock opened at $66.80 on Monday. The company's 50 day simple moving average is $64.99 and its 200-day simple moving average is $53.57. The firm has a market capitalization of $11.12 billion, a PE ratio of 79.52 and a beta of 1.49. Cognex Corporation has a 12 month low of $32.55 and a 12 month high of $72.88.
Cognex (NASDAQ:CGNX - Get Free Report) last issued its quarterly earnings data on Wednesday, May 6th. The scientific and technical instruments company reported $0.34 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.25 by $0.09. Cognex had a return on equity of 10.89% and a net margin of 13.62%.The firm had revenue of $268.44 million during the quarter, compared to the consensus estimate of $245.98 million. During the same period in the previous year, the firm posted $0.14 EPS. The company's quarterly revenue was up 24.3% compared to the same quarter last year. Cognex has set its Q2 2026 guidance at 0.400-0.440 EPS. As a group, sell-side analysts anticipate that Cognex Corporation will post 1.48 earnings per share for the current year.
Cognex Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Thursday, June 4th. Stockholders of record on Thursday, May 21st were given a dividend of $0.085 per share. The ex-dividend date of this dividend was Thursday, May 21st. This represents a $0.34 dividend on an annualized basis and a dividend yield of 0.5%. Cognex's dividend payout ratio (DPR) is presently 40.48%.
Insider Transactions at Cognex
In other news, VP Laura Ann Macdonald sold 41,600 shares of the business's stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $65.56, for a total value of $2,727,296.00. Following the completion of the sale, the vice president owned 5,258 shares of the company's stock, valued at approximately $344,714.48. The trade was a 88.78% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Darren Marc Long sold 20,252 shares of the stock in a transaction dated Wednesday, May 27th. The stock was sold at an average price of $66.34, for a total transaction of $1,343,517.68. Following the transaction, the vice president directly owned 3,990 shares in the company, valued at $264,696.60. The trade was a 83.54% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 224,847 shares of company stock valued at $14,975,098. 1.70% of the stock is currently owned by corporate insiders.
Analyst Ratings Changes
A number of research firms have commented on CGNX. Weiss Ratings restated a "hold (c)" rating on shares of Cognex in a research note on Friday, May 15th. Needham & Company LLC lifted their price objective on Cognex from $67.00 to $75.00 and gave the company a "buy" rating in a research note on Friday, May 8th. JPMorgan Chase & Co. upgraded Cognex from a "neutral" rating to an "overweight" rating and boosted their price objective for the company from $65.00 to $75.00 in a report on Tuesday, May 26th. The Goldman Sachs Group reissued a "buy" rating and set a $80.00 target price (up from $70.00) on shares of Cognex in a research note on Monday, May 11th. Finally, Stephens raised their target price on Cognex from $65.00 to $75.00 and gave the company an "overweight" rating in a report on Thursday, May 7th. Two equities research analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating and four have issued a Hold rating to the company's stock. According to MarketBeat, Cognex currently has a consensus rating of "Moderate Buy" and an average price target of $72.00.
Read Our Latest Analysis on CGNX
Cognex Company Profile
(
Free Report)
Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.
The company's product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cognex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cognex wasn't on the list.
While Cognex currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.